In situ lung perfusion is a valuable tool to assess lungs from donation after circulatory death donors category I-II

Transplant International

Volumn 26, Issue 5, 2013, Pages 485-492

  Van De Wauwer, Caroline ^a   Munneke, Anita J ^a   Engels, Gerwin E ^a   Berga, Foke M ^a   Rakhorst, Gerhard ^a   Nijsten, Maarten W ^a   Mariani, Massimo A ^a   Erasmus, Michiel E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

category I II; donation after circulatory death; ISLP; lactate; lung transplantation

Indexed keywords

AIRWAY PRESSURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; COOLING; DOMESTIC PIG; DRY WEIGHT; HEART VENTRICLE FIBRILLATION; ISCHEMIA; LUNG COMPLIANCE; LUNG PERFUSION; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; NONHUMAN; PRESSURE; PRIORITY JOURNAL; RESUSCITATION;

ANIMALS; CARBON DIOXIDE; DEATH; LACTIC ACID; LUNG; LUNG COMPLIANCE; LUNG TRANSPLANTATION; PERFUSION; RESPIRATORY FUNCTION TESTS; SUS SCROFA; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WARM ISCHEMIA;

EID: 84876489076     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12068     Document Type: Article

References (27)

1. Hornby K, Ross H, Keshavjee S, Rao V, Shemie SD,. Non-utilization of hearts and lungs after consent for donation: a Canadian multicentre study. Can J Anaesth 2006; 53: 831.
2. Cypel M, Keshavjee S,. The clinical potential of ex vivo lung perfusion. Expert Rev Respir Med 2012; 6: 27.
3. Cypel M, Keshavjee S,. Extracorporeal lung perfusion. Curr Opin Organ Transplant 2011; 16: 469.
4. Rodriguez DA, Del Rio F, Fuentes ME, et al,. Lung transplantation with uncontrolled non-heart-beating donors. Transplantation. Donor prognostic factor and immediate evolution post transplant. Arch Bronconeumol 2011; 47: 403.
5. Van Raemdonck DE, Jannis NC, De Leyn PR, Flameng WJ, Lerut TE,. Warm ischemic tolerance in collapsed pulmonary grafts is limited to 1 hour. Ann Surg 1998; 228: 788.
6. Novick RJ, Gehman KE, Ali IS, Lee J,. Lung preservation: the importance of endothelial and alveolar type II cell integrity. Ann Thorac Surg 1996; 62: 302.
7. Inci I, Arni S, Acevedo C, et al,. Surfactant alterations following donation after cardiac death donor lungs. Transpl Int 2011; 24: 78.
8. Allison RC, Kyle J, Adkins WK, Prasad VR, McCord JM, Taylor AE,. Effect of ischemia reperfusion or hypoxia reoxygenation on lung vascular permeability and resistance. J Appl Physiol 1990; 69: 597.
9. Van De Wauwer C, Neyrinck AP, Geudens N, et al,. Retrograde flush following warm ischemia in the non-heart-beating donor results in superior graft performance at reperfusion. J Surg Res 2009; 154: 118.
10. Moradiellos Diez FJ, Naranjo JM, Cordoba M, et al,. First successful transplantations after ex vivo evalutation of uncontrolled non-heart-beating donor human lungs. Interact Cardio Vasc Thorac Surg 2010; 11: S18.
11. Cypel M, Yeung JC, Liu M, et al,. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med 2011; 364: 1431.
12. Van Raemdonck D,. Thoracic organs: current preservation technology and future prospects; part 1: lung. Curr Opin Organ Transplant 2010; 15: 150.
13. Dark JH,. Lung transplantation from the non-heart beating donor. Transplantation 2008; 86: 200.
14. Egan TM, Lambert CJ, Reddick R, Ulicny KS, Keagy BA, Wilcox BR,. A strategy to increase the donor pool: use of cadaver lungs for transplantation. Ann Thorac Surg 1991; 5: 1113.
15. Hayama M, Date H, Oto T, Aoe M, Andou A, Shimizu N,. Improved lung function by means of retrograde flush in canine lung transplantation with non-heart-beating donors. J Thorax Cardiovasc Surg 2003; 125: 901.
16. Yeung JC, Cypel M, Machuca TN, et al,. Physiologic assessment of the ex vivo donor lung for transplantation. J Heart Lung Transplant 2012; 31: 1120.
17. Perlman CE, Lederer DJ, Bhattacharya J,. Micromechanics of alveolar edema. Am J Respir Cell Mol Biol 2011; 44: 34.
18. D'Alonzo GE, Dantzker DR,. Respiratory failure, mechanisms of abnormal gas exchange, and oxygen delivery. Med Clin North Am 1983; 67: 557.
19. Fisher AB,. Intermediary metabolism of the lung. Environ Health Perspect 1984; 55: 149.
20. Sanchez PG, Bittle GJ, Burdorf L, Pierson RN III, Griffith BP,. State of Art: Clinical ex vivo lung perfusion: Rationale, current status, and future directions. J Heart Lung Transplant 2012; 31: 339.
21. Eldridge F,. Blood lactate and pyruvate in pulmonary insufficiency. N Engl J Med 1966; 274: 878.
22. Mitchell AM, Cournand A,. The fate of circulating lactic acid in the human lung. J Clin Invest 1955; 34: 471.
23. Brown SD, Clark C, Gutierrez G,. Pulmonary lactate release in patients with sepsis and the adult respiratory distress syndrome. J Crit Care 1996; 11: 2.
24. Bellomo R, Kellum JA, Pinsky MR,. Transvisceral lactate fluxes during early endotoxemia. Chest 1996; 110: 198.
25. Kellum JA, Kramer DJ, Lee K, Mankad S, Bellomo R, Pinsky MR,. Release of lactate by the lung in acute lung injury. Chest 1997; 111: 1301.
26. Koike T, Yeung JC, Cypel M, et al,. Kinetics of lactate metabolism during acellular normothermic ex vivo lung perfusion. J Heart Lung Transplant 2011; 30: 1312.
27. Seeley EJ, McAuley DF, Eisner M, et al,. Decreased respiratory system compliance on the sixth day of mechanical ventilation is a predictor of death in patients with established acute lung injury. Respir Res 2011; 12: 52.